Plant compounds like caffeine, L-theanine, tryptamines, and polyphenols can alter brain function, potentially influencing ...

One of the major breakthroughs over the last couple of years has been a potential new diagnostic test for Parkinson’s – a ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...

Jackie seemed to be on the right path in her 20s; she was smart and successful, working for several years as a manager at high-end restaurants. But in her late teens, she began ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

In a breakthrough for people with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication, which will be marketed under the name ...

The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration ...

The US Food and Drug Administration has approved the new drug Cobenfy, which is owned by pharmaceutical firm Bristol Myers Squibb.

Dementia therapies may help relieve symptoms, but many different options are available. Some may help more than others.

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

In a year where insurers have expanded coverage for multiple medical treatments, federal employees will see their Federal ...

As we age, keeping our independence is key. At Seniors Helping Seniors®, we offer affordable, professional care at home. Our team, made up of seniors, knows how vital it is to stay in one's own home.